Therapeutic strategies targeting Caspase-3 cleavage of SPTBN1 or modulating nuclear translocation of SPTBN1 cleavage products could mitigate obesity-related metabolic dysregulation (Fig
Meet the Experts Our panel features thought leaders in obesity treatment and precision medicine, including: Andres Acosta , MD, PhD, Associate Professor of Medicine, Co-Director of Nutrition Obesity Research Center, and Director of Precision Medicine for Obesity Program, Mayo Clinic Jaime Almandoz , MD, Medical Director, Weight Wellness Program, and Associate Professor of Internal Medicine, University of Texas Southwestern Medical Center Noor Khan , MD, Associate Program Director, UPMC Obesity Medicine Fellowship Program David Rometo , MD, Clinical Director, UPMC Center for Obesity Medicine, and Clinical Associate Professor of Medicine, University of Pittsburgh Who Should Attend
Do not change the schedule without medical advice
A pharmacist may be able to run a test claim before filling the prescription
The peptide research community has spent thirty years studying BPC-157 in various animal models, and the safety data accumulated during that time tells a more complete story than internet warnings suggest